Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
02 2019
Historique:
received: 13 06 2018
revised: 26 07 2018
accepted: 17 08 2018
pubmed: 10 10 2018
medline: 18 12 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is further associated with progressive cognitive decline. In respect to motor phenotype, there is some evidence that akinetic-rigid PD is associated with a faster rate of cognitive decline in general and a greater risk of developing dementia.The objective of this study was to examine cognitive profiles among patients with PD by motor phenotypes and its relation to cognitive function. Demographic, clinical and neuropsychological cross-sectional baseline data of the DEMPARK/LANDSCAPE study, a multicentre longitudinal cohort study of 538 patients with PD were analysed, stratified by motor phenotype and cognitive syndrome. Analyses were performed for all patients and for each diagnostic group separately, controlling for age, gender, education and disease duration. Compared with the tremor-dominant phenotype, akinetic-rigid patients performed worse in executive functions such as working memory (Wechsler Memory Scale-Revised backward; p=0.012), formal-lexical word fluency (p=0.043), card sorting (p=0.006), attention (Trail Making Test version A; p=0.024) and visuospatial abilities (Leistungsprüfungssystem test 9; p=0.006). Akinetic-rigid neuropsychological test scores for the executive and attentive domain correlated negatively with non-tremor motor scores. Covariate-adjusted binary logistic regression analyses showed significant odds for PD-mild cognitive impairment for not-determined as compared with tremor-dominant (OR=3.198) and akinetic-rigid PD (OR=2.059). The odds for PD-dementia were significant for akinetic-rigid as compared with tremor-dominant phenotype (OR=8.314). The three motor phenotypes of PD differ in cognitive performance, showing that cognitive deficits seem to be less severe in tremor-dominant PD. While these data are cross-sectional, longitudinal data are needed to shed more light on these differential findings.

Identifiants

pubmed: 30297519
pii: jnnp-2018-319008
doi: 10.1136/jnnp-2018-319008
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-179

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: GD has received lecture fees from Boston Scientific and has been serving as a consultant for Boston Scientific. He received royalties from Thieme Publishers. He is a government employee and receives through his institution funding for his research from the German Research Council, the German Ministry of Education and Research, and Medtronic. KW received reimbursement of congress fees from BIAL and Desitin; and grants from the Federal Ministry of Education and Research and the German Research Foundation.

Auteurs

Jennifer Wojtala (J)

Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany.
JARA-Brain Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Ines Ann Heber (IA)

Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany.

Petra Neuser (P)

Coordinating Center for Clinical Trials, Philipps-University of Marburg, KKS Marburg, Marburg, Germany.

Julia Heller (J)

Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany.
JARA-Brain Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Elke Kalbe (E)

Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), University Hospital Cologne, Cologne, Germany.

Sarah P Rehberg (SP)

Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), University Hospital Cologne, Cologne, Germany.

Alexander Storch (A)

Division of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Department of Neurology, University of Rostock, Rostock, Germany.

Katharina Linse (K)

Division of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.

Christine Schneider (C)

Division of Neurodegenerative Diseases, Department of Neurology, Technische Universität Dresden, Dresden, Germany.

Susanne Gräber (S)

German Center of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (DZNE), Tübingen, Germany.

Daniela Berg (D)

German Center of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (DZNE), Tübingen, Germany.
Department of Neurology, Christian Albrecht University, Kiel, Germany.

Judith Dams (J)

Department of Neurology, Philipps University Marburg, Marburg, Germany.

Monika Balzer-Geldsetzer (M)

Department of Neurology, Philipps University Marburg, Marburg, Germany.
Department of Geriatric Medicine, University Hospital Essen, Essen, Germany.

Rüdiger Hilker-Roggendorf (R)

Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), University Hospital Cologne, Cologne, Germany.

Carola Oberschmidt (C)

Department of Neurology, J.W. Goethe University, Frankfurt/Main, Germany.

Simon Baudrexel (S)

Department of Neurology, J.W. Goethe University, Frankfurt/Main, Germany.

Karsten Witt (K)

Research Center Neurosensory Science, Department of Neurology, School of Medicine and Health Sciences - European Medical School,University Oldenburg, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

Nele Schmidt (N)

Department of Neurology, Christian Albrecht University, Kiel, Germany.

Günther Deuschl (G)

German Center of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (DZNE), Tübingen, Germany.

Brit Mollenhauer (B)

Paracelsus-Elena Clinic, Centre of Parkinsonism and Movement Disorders, Department of Neurology (BM) and Department of Neurosurgery (CT), Paracelsus-Elena Clinic, University Medical Center Goettingen, Kassel, Germany.

Claudia Trenkwalder (C)

Paracelsus-Elena Clinic, Centre of Parkinsonism and Movement Disorders, Department of Neurology (BM) and Department of Neurosurgery (CT), Paracelsus-Elena Clinic, University Medical Center Goettingen, Kassel, Germany.

Inga Liepelt-Scarfone (I)

German Center of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research (DZNE), Tübingen, Germany.

Annika Spottke (A)

Department of Neurology, University Hospital Bonn, and German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Sandra Roeske (S)

Department of Neurology, University Hospital Bonn, and German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Ullrich Wüllner (U)

Department of Neurology, University Hospital Bonn, and German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Hans-Ulrich Wittchen (HU)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, München, München, Germany.

Oliver Riedel (O)

Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.

Richard Dodel (R)

Department of Neurology, Philipps University Marburg, Marburg, Germany.
Department of Geriatric Medicine, University Hospital Essen, Essen, Germany.

Jörg B Schulz (JB)

Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany.
JARA-Brain Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Kathrin Reetz (K)

Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany kreetz@ukaachen.de.
JARA-Brain Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH